Metastatic renal cell carcinoma occurs when kidney cancer spreads beyond the kidney to other parts of the body, most commonly the lungs, bones, brain, or liver. While this advanced stage of kidney cancer presents serious challenges and is typically not curable, modern treatments can often help control the disease, manage symptoms, and improve quality of life for months or even years.

Understanding Metastatic Kidney Cancer

Metastatic renal cell carcinoma, also called stage IV kidney cancer or advanced kidney cancer, represents the most serious form of kidney cancer. Renal cell carcinoma is a disease where cancer cells form in the tubules of the kidney, which are the tiny tubes that filter and clean the blood. It accounts for about 90% of all kidney cancers in adults^[2].

When doctors say the cancer is metastatic, they mean it has spread from where it started in the kidney to other organs or tissues in the body. This spreading happens when cancer cells break away from the original tumor and travel through the body’s network of blood vessels or the lymph system, which is a network similar to blood vessels that helps the body fight disease^[1].

The cancer typically spreads in stages. First, the tumor grows larger within the kidney, then it may spread into the fat or major blood vessels around the kidney. From there, it can reach the adrenal gland, which sits right on top of the kidney. Eventually, cancer cells can travel farther through the bloodstream or lymph system to distant parts of the body^[1].

Unfortunately, kidney cancer often has no symptoms in its early stages, which means it can spread before a person even knows they have it. Many kidney tumors are discovered accidentally during imaging tests like CT scans or ultrasounds performed for other reasons. If the cancer does get caught early but treatment doesn’t eliminate all cancer cells, the disease can return and spread later^[1].

Where Kidney Cancer Spreads

Metastatic renal cell carcinoma most often travels to the lungs and bones. However, the cancer has the capacity to appear almost anywhere in the body. Other common sites where kidney cancer spreads include the brain, liver, and adrenal glands^[1][5].

When multiple organs are affected, it becomes more complex to manage. Approximately 33% of patients with renal cell cancer develop metastatic spread. More than one organ system is often involved in the metastatic process. Metastases may be found at the time of initial diagnosis, or they may appear at some interval after the kidney has been surgically removed^[5].

The way cancer spreads determines where it ends up. Cancer cells that enter blood vessels can travel through veins and arteries to reach many different body parts. Those that get into lymph nodes can use the lymph system as a highway to other organs. The location where the cancer spreads can influence what symptoms a person experiences and which treatment options might work best^[1].

Epidemiology and Statistics

Kidney cancer represents a significant global health concern. Worldwide, there are an estimated 400,000 cases of kidney cancer diagnosed each year, along with approximately 175,000 deaths. In the United States, kidney cancer is the eighth most common malignancy^[11].

In the United States specifically, it is estimated that around 80,980 new cases of kidney and renal pelvis cancer will be diagnosed in 2025, with about 14,510 deaths expected from the disease^[8]. These numbers highlight the serious nature of this disease and the importance of early detection and treatment.

The survival statistics vary dramatically depending on when the cancer is caught. When kidney cancer is diagnosed while still localized to the kidney and hasn’t spread beyond it, the five-year survival rate is quite good at 93%. However, once the cancer becomes metastatic and spreads to other parts of the body, the five-year survival rate drops significantly to about 12%^[11].

About half of kidney tumors are discovered during CT scans or X-rays performed for other reasons. Approximately 20% to 50% of patients who undergo surgery to remove their kidney later develop metastases at some point after the initial treatment^[5][6].

Causes and Risk Factors

Renal cell cancer develops when certain changes occur in how kidney cells function, particularly affecting how they grow and divide. While the exact cause isn’t always clear, several risk factors can increase the likelihood of developing this disease. These risk factors don’t directly cause cancer but rather increase the chance of DNA damage in cells that may lead to cancer^[3].

Smoking tobacco is one of the most significant risk factors for renal cell cancer. Tobacco use is a leading cause of cancer and death from cancer in general. The harmful chemicals in tobacco can damage kidney cells over time, increasing cancer risk. The good news is that this risk factor can be changed by quitting smoking^[3].

The misuse of certain pain medicines, including some over-the-counter pain medications, over a long period has been linked to an increased risk of kidney cancer. Having excess body weight and high blood pressure also contribute to higher risk. These factors may affect kidney function and increase the likelihood of cellular changes that can lead to cancer^[3].

Family history plays a role as well. Having a family history of renal cell cancer increases risk, as does having certain genetic conditions such as von Hippel-Lindau disease or hereditary papillary renal cancer. These inherited conditions can make individuals more susceptible to developing kidney tumors^[3].

Symptoms and How They Affect Daily Life

The symptoms of metastatic renal cell carcinoma can vary significantly from person to person. In most cases, people will notice blood in their urine, which can be alarming. Beyond this, many people feel generally unwell, experiencing persistent tiredness and a loss of appetite that makes eating unappealing^[1].

Common symptoms that people with advanced kidney cancer experience include a fever that comes and goes without an obvious cause. Some notice a lump or mass in their belly that they can feel. Night sweats can become so severe that people need to change their clothes or bed sheets during the night. Pain in the back or side that won’t go away is another frequent complaint. Unexplained weight loss, where pounds drop off without trying, is also common^[1].

Where the cancer has spread often determines what additional symptoms appear. If the cancer reaches the bones, it can cause pain in those specific areas. When cancer spreads to the lungs, it may lead to a persistent cough or difficulty breathing. Brain metastases might cause headaches or other neurological symptoms. These symptoms can significantly impact a person’s ability to carry out normal daily activities and enjoy life^[1].

The disease and its treatments can cause extreme fatigue that wipes people out completely. This exhaustion is different from ordinary tiredness and doesn’t improve much with rest. The combination of symptoms, along with the emotional burden of dealing with cancer, can make even simple tasks feel overwhelming^[1].

How the Disease Is Diagnosed

When doctors suspect metastatic renal cell carcinoma, they perform various tests to confirm the diagnosis and determine how far the cancer has spread. These tests help create an effective treatment plan tailored to each person’s specific situation^[6].

The diagnostic process typically starts with a physical exam to check overall health, including vital signs like blood pressure, temperature, weight, and pulse. Doctors will ask detailed questions about medications, other health conditions, previous health test results, and whether any family members have had kidney cancer or other diseases^[6].

Blood tests are essential for checking how well the kidneys are working and assessing overall health. A Complete Blood Count measures the number of different types of cells in the blood, including red blood cells, white blood cells, and platelets. Blood chemistry tests evaluate liver and kidney function and check levels of important substances like sodium and potassium. A urinalysis examines the urine for blood, extra proteins, or signs of infection^[6].

Imaging tests provide detailed pictures of what’s happening inside the body. A CT scan uses X-rays to create detailed images and is commonly used to scan the abdomen and pelvis to see the kidneys and nearby areas, helping determine if cancer has spread. Before the scan, patients may receive a contrast substance either by mouth or through an injection to improve image quality^[6].

An MRI uses radio waves and powerful magnets to take pictures of the body and can check if kidney cancer has spread to major blood vessels or the brain. A chest X-ray looks for evidence that cancer has spread to the lungs. If something suspicious appears on the X-ray, doctors may order a chest CT scan for a more detailed look. A bone scan uses a small amount of radioactive material to detect whether cancer has spread to the bones^[6].

Sometimes doctors perform a biopsy, which involves removing a small sample of tissue to examine under a microscope. However, for kidney cancer, a biopsy isn’t always necessary if imaging clearly shows a kidney tumor^[6].

Treatment Approaches

While metastatic renal cell carcinoma typically cannot be cured, many treatment options exist to help control the disease, manage symptoms, and improve quality of life. The goal of treatment at this stage is to slow the cancer’s growth and help patients feel as comfortable as possible for as long as possible^[1][4].

Surgery

Surgery remains an important treatment option even when cancer has spread. In a procedure called radical nephrectomy, surgeons remove the kidney containing the tumor along with the adrenal gland sitting on top of it, nearby lymph nodes, and fat surrounding the organ. If the cancer hasn’t spread extensively, surgery may help people live longer and can also relieve symptoms like pain and bleeding^[12].

For some patients, doctors recommend a cytoreductive nephrectomy before starting other treatments. This surgery removes the kidney with the tumor and as much cancer as possible. Research suggests this approach may improve how well patients respond to subsequent treatments like targeted therapy^[13].

Sometimes surgery is used to remove cancer that has spread to other organs like the brain or lungs. If a person isn’t healthy enough for major surgery, less invasive options exist, including procedures that use extreme cold or heat to destroy tumor tissue^[12].

Targeted Therapy

Targeted therapy has become the main treatment for stage IV kidney cancer. These drugs work differently than traditional chemotherapy. Targeted therapy uses medicines that target specific molecules on or inside cancer cells that help them grow and divide. By targeting these molecules, the drugs can stop cancer growth while limiting damage to normal cells^[13].

Several types of targeted therapy drugs treat metastatic kidney cancer. Some work on a protein called VEGF (vascular endothelial growth factor), which helps tumors build blood vessels they need to grow larger. Drugs like sunitinib, pazopanib, sorafenib, cabozantinib, and axitinib all target this pathway. Sunitinib is often the first drug used because studies show it’s highly effective^[13].

Other targeted drugs work on a protein called mTOR (mammalian target of rapamycin), which helps cells grow and divide. Drugs like temsirolimus and everolimus target this protein. Another drug, lenvatinib, blocks tyrosine kinase, a protein on cell surfaces that sends growth signals^[13].

Doctors consider many factors when choosing which targeted therapy to use, including the specific type of kidney cancer, previous treatments, and certain predictors of how well someone might respond to treatment^[13].

Immunotherapy

Immunotherapy works by strengthening or restoring the immune system’s natural ability to find and destroy cancer cells. This treatment approach has tremendously changed outcomes for patients with metastatic kidney cancer^[11].

Several immunotherapy drugs are now approved for treating kidney cancer. These include checkpoint inhibitors that target pathways called PD-1/PD-L1 and CTLA-4, which cancer cells use to hide from the immune system. Drugs like nivolumab, avelumab, and ipilimumab fall into this category. Sometimes doctors use these drugs alone, and sometimes they combine them with each other or with targeted therapy drugs^[11][12].

Older forms of immunotherapy using substances called cytokines, specifically interleukin-2 and interferon-alpha, were once commonly used. These immune-stimulating chemicals can cause kidney cancers to shrink in about 10-20% of patients. However, today they’re used less frequently because newer immunotherapies tend to work better and have fewer serious side effects^[11].

Radiation Therapy

Radiation therapy uses high-energy X-rays to kill cancer cells. While it’s most often used for advanced kidney cancer, the primary goal is to control symptoms rather than cure the disease. Radiation can help relieve pain, especially when cancer has spread to bones or other areas causing discomfort. It can also help control bleeding and other symptoms related to where the cancer has spread^[4][12].

Other Treatment Options

Chemotherapy, which uses drugs to kill rapidly dividing cells, tends to be less effective for kidney cancer compared to other cancers. For this reason, it’s not commonly used as a first-line treatment. However, in some specific situations, chemotherapy drugs like gemcitabine may be combined with targeted therapies^[12][13].

Living with Metastatic Kidney Cancer

Receiving a diagnosis of metastatic renal cell carcinoma can feel overwhelming and shocking. It’s completely normal to feel uncertain, anxious, and unable to think about anything else initially. Many people experience a range of difficult emotions, and there’s no right or wrong way to feel^[14].

Managing daily life with advanced kidney cancer requires attention to both physical and emotional well-being. Pacing yourself becomes essential, as cancer and its treatments can be exhausting. Keeping days simple and saving energy for important activities helps conserve strength. Don’t hesitate to rest whenever needed^[1].

Staying active, even in small ways, can make a significant difference. Exercise helps lift energy levels and fights off anxiety, depression, and stress. Even light physical activity like walking or gentle stretching can help. Always check with your doctor about what level of activity is safe for your specific situation^[1].

Eating a healthy diet with plenty of fresh fruits, vegetables, whole grains, and lean proteins supports overall health and helps maintain strength. If you’ve had a kidney removed but your remaining kidney is healthy, you generally won’t need to follow special dietary restrictions. However, if your remaining kidney isn’t functioning optimally, you may need to limit protein, salt, phosphorus, and potassium. A dietitian specializing in kidney disease can provide personalized guidance^[15].

Communication with your healthcare team is crucial. Don’t suffer in silence with treatment side effects or symptoms. Doctors can help manage common problems like constipation, upset stomach, and pain, but only if they know what’s happening. Keeping a journal to track symptoms, when they occur, and what you’re doing can help identify patterns and guide treatment adjustments^[1].

Managing stress through relaxation techniques can improve mood and overall well-being. Methods like meditation, deep breathing, or engaging in enjoyable hobbies provide mental relief. Some people find comfort in spiritual practices or talking with religious leaders. Finding what works for you personally is what matters most^[1][14].

Prognosis and Living with Uncertainty

When cancer has metastasized, the prognosis varies greatly depending on many factors. Doctors use risk stratification systems to estimate survival and help guide treatment decisions. The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) classification system evaluates six criteria including how long it took from diagnosis to needing systemic therapy, performance status, and specific blood test results. Based on these factors, patients are classified into favorable-risk, intermediate-risk, or poor-risk groups, each with different median survival times^[7].

While statistics provide general information, every person’s experience is unique. Some patients survive much longer than average predictions, while others face more rapid progression. Occasionally, patients with advanced disease may experience slow-growing cancer that remains stable for years. Late tumor recurrence many years after initial treatment can also occur. In very rare cases, well-documented instances of spontaneous tumor regression have occurred without treatment, though this is extremely uncommon^[8].

Modern treatment advances have significantly improved outcomes for many patients with metastatic kidney cancer. The development of targeted therapies and immunotherapies has changed the treatment landscape, offering hope where previously few options existed. Some patients achieve remarkable disease control, living active lives for extended periods while on treatment^[11].

The Importance of Follow-Up Care

Regular follow-up appointments with your healthcare team are critical when living with metastatic kidney cancer. These visits allow doctors to monitor how well treatments are working, check for side effects, and adjust the treatment plan as needed. Imaging tests and blood work performed at these appointments provide important information about disease status^[1].

Attending all scheduled appointments ensures your medical team stays informed about your condition. If you’re experiencing new or worsening symptoms, or if side effects are interfering with your quality of life, don’t wait until your next scheduled visit to contact your doctor. Many issues can be addressed promptly with medication adjustments or supportive care measures^[1].

Your body can function normally with just one kidney if the remaining kidney is healthy. Doctors will perform regular checkups to ensure the remaining kidney continues working well. If kidney function declines, additional monitoring and possible adjustments to medications or diet may be necessary^[15].